Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 DiabetesDeborah J. Wexler, Gabriela Montes, Ian H. de Boer et al.|JAMA Internal Medicine|2023Cited by 38
The Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early ResultsJosé C. Florez, Elizabeth Kubota-Mishra, Pengfei Liu et al.|Diabetes Care|2023Cited by 17
Glucose-Lowering Medications, Glycemia, and Cognitive OutcomesJosé A. Luchsinger, Erica Gonzalez, Samuel P. Rosin et al.|JAMA Internal Medicine|2025Cited by 10
Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled TrialDeborah J. Wexler, J Jimenez, W. Timothy Garvey et al.|Diabetes Care|2025Cited by 4
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)Kristina M. Utzschneider, E. Gonzalez Hattery, Mark Tripputi et al.|Diabetes Care|2025Cited by 2